| 33 | 💬 0 |
Obinutuzumab beta for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.
(nature.com)
|
Nature Medicine 2026-08-10 | #nmosd #clinical trial #immunotherapy #autoimmunity #neuroinflammation |